Adcounty Media Q2 FY27 Net Profit Drops 38.4% YoY to Rs 2.68 Cr Despite 33% Revenue Growth
Adcounty Media reported its standalone results for Q2 FY27 (quarter ended Sep 30, 2026), with revenue from operations growing 32.9% YoY to Rs 22.20 Cr compared to Rs 16.70 Cr in Q2 FY26. However, net profit fell 38.4% YoY to Rs 2.68 Cr from Rs 4.35 Cr, driven by higher cost of traded media which jumped to Rs 16.19 Cr from Rs 9.25 Cr. Sequentially, revenue dipped 3.8% and PAT contracted 43.1% from Rs 4.71 Cr in Q1 FY27. For H1 FY27, revenue reached Rs 45.28 Cr with a net profit of Rs 7.40 Cr.
high confidence
What changedAdcounty Media declared its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026.
Why it mattersOperating margins have seen sharp compression due to rising media costs, leading to a substantial drop in net profit despite healthy topline growth.
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
Readymix H1 FY27 Revenue Jumps 47.6% YoY to ₹40.82 Cr; Net Profit Rises 19.1% to ₹0.92 Cr
Readymix Construction Machinery reported standalone revenue of ₹40.82 Cr for the half year ended September 30, 2026, marking a 47.6% YoY growth over ₹27.65 Cr in H1 FY26. Net profit increased 19.1% YoY to ₹0.92 Cr compared to ₹0.78 Cr in the corresponding previous period. Sequentially, revenue dropped 35.2% from ₹62.96 Cr in H2 FY26, consistent with the company's historical skew toward strong fourth-quarter performance. Operating cash flows remained negative at -₹9.27 Cr for H1 FY27, driven primarily by an inventory buildup of ₹18.57 Cr.
high confidence
What changedReadymix released its un-audited standalone financial results for the half year ended September 30, 2026.
Why it mattersShows strong YoY top-line recovery in H1, though substantial working capital blockage in inventory has pushed up short-term debt and kept operating cash flow negative.
📅 Short termThe market is likely to react positively to the 47.6% YoY top-line growth, but cash flow deficits and elevated short-term borrowings may weigh on sentiment.
📈 Long termExecution in H2 remains the key driver for profitability given business seasonality, with ongoing in-house component development key to sustaining long-term operating margins.
⚠ Risk flags
Negative operating cash flow of -₹9.27 Cr in H1 FY27
Sharp increase in short-term borrowings from ₹16.25 Cr to ₹31.17 Cr
Significant working capital stretch with inventory rising to ₹57.71 Cr
👀 What to Watch
Track whether working capital normalizes and inventory unwinds into billings in H2 FY27, alongside monitoring debt repayment trends.
Infomerics Upgrades Morepen Laboratories' Bank Facilities Credit Rating to IVR A/Stable
Credit rating agency Infomerics Valuation and Rating Limited has upgraded the rating of Morepen Laboratories' bank facilities to 'IVR A/ Stable' via its letter dated November 13, 2026. The upgrade reflects improving operational metrics and debt-servicing capability, backed by recent strong earnings growth where TTM PAT reached Rs 189 Cr. With a total debt of Rs 315 Cr and a conservative debt-to-equity ratio of 0.23, the upgraded rating is likely to assist the company in lowering its cost of debt capital.
high confidence
What changedInfomerics upgraded the credit rating for Morepen Laboratories Limited's bank facilities to 'IVR A/ Stable'.
Why it mattersA rating upgrade improves creditworthiness, facilitating better borrowing terms and reduced borrowing costs on its Rs 315 Cr debt.
New Credit Rating: IVR A/ StableRating Action Date: 13th November 2026Total Debt: Rs 315 CrDebt to TTM Revenue Ratio: ~13.8%
📅 Short termPositive sentiment indicator reflecting company fundamentals and strengthening financial profile.
📈 Long termEnhances financial flexibility to fund capacity expansions in medical devices and API facilities at competitive interest rates.
⚠ Risk flags
Pricing pressures from Chinese API competitors
Dependency on legacy APIs
👀 What to Watch
Track if the improved rating translates into lower finance costs and interest savings in upcoming quarterly earnings reports.
Ajax Engg Q2/H1 FY27 Call: SLCM Market Share Rises to 75.5%, Cash Reserves at ₹1,150 Cr
Ajax Engineering released its Q2 and H1 FY27 earnings call transcript highlighting continued dominance in the Self-Loading Concrete Mixer (SLCM) segment with retail market share expanding 480 bps year-on-year to 75.5%. Despite headwinds from elevated steel prices and state-level infrastructure slowdowns, export revenue surged 47% YoY during H1 FY27. The company maintains strong liquidity with nearly ₹1,150 crore in cash reserves. To protect margins against mid-single-digit raw material cost inflation, Ajax implemented a ~1% price hike in September following a ~2% hike in Q4 FY26.
high confidence
What changedSubmission of the formal transcript for the Q2 & H1 FY27 earnings conference call held on November 6, 2026.
Why it mattersProvides granular operational insights into market share defense (75.5% in SLCM), cost pressure mitigations, export traction, and deployment of ₹1,150 crore cash reserves.
📅 Short termRoutine disclosure post-earnings; market will watch for recovery in state infrastructure contract payments and margin stability across H2 FY27.
📈 Long termStrong cash chest of ₹1,150 crore and a dominant 75.5% SLCM market share provide substantial resilience and optionality for non-SLCM portfolio expansion.
⚠ Risk flags
Delays in state infrastructure project execution and contractor payments in states like Maharashtra, Rajasthan, MP, and Bihar
Raw material cost pressures from steel and crude-linked inputs
👀 What to Watch
Monitor whether calibrated price hikes sufficiently offset mid-single-digit raw material inflation and track execution updates on non-SLCM diversification (batching plants and pumps).
GPT Healthcare Reports Q2 FY27 Net Profit Up 45.2% to ₹15.4 Cr; EBITDA Margin at 21.5%
GPT Healthcare reported its Q2 FY27 earnings call transcript, highlighting strong operational performance with Q2 revenue rising 14.1% YoY to ₹135.6 crore and net profit jumping 45.2% YoY to ₹15.4 crore. EBITDA expanded 23.9% YoY to ₹29.8 crore with margins improving 150 bps to 21.5%, driven by higher ARPOB (₹40,721) and improved network occupancy of 50.3%. For H1 FY27, revenue reached ₹261.8 crore and PAT surged 53.9% to ₹28.1 crore. Management expects the Raipur hospital to incur about ₹10 crore EBITDA loss in FY27 before turning slightly positive in FY28, while the upcoming 155-bed Jamshedpur hospital is slated for launch in March-April 2027.
high confidence
What changedGPT Healthcare filed the full transcript of its Q2 and H1 FY27 earnings conference call.
Why it mattersShows operational operating leverage across mature hospitals and clarifies breakeven timelines and EBITDA drag for new expansion facilities in Raipur and Jamshedpur.
📅 Short termPositive operating numbers and strong margin expansion demonstrate solid execution, though market may digest ongoing startup losses from newer units.
📈 Long termCompany aims for 25% ROE/ROCE through network utilization and expansion into underserved Tier-2 East/Central Indian hubs like Raipur and Jamshedpur.
⚠ Risk flags
Competition and doctor talent attrition in new markets (noted specifically in Raipur from peers like Artemis)
Execution and gestation losses (~₹10 crore each) for Raipur in FY27 and Jamshedpur in FY28
👀 What to Watch
Monitor the pace of occupancy ramp-up at Raipur toward breakeven and track the commissioning progress of the 155-bed Jamshedpur facility planned for March-April 2027.
Sammaan Capital Q2 FY27 Interest Income at Rs 1,161 Cr; Reports Security Cover of 1.21x
Sammaan Capital reported its unaudited financial results for the quarter and half-year ended September 30, 2026. Consolidated interest income for Q2 stood at Rs 1,161.26 Cr compared to Rs 1,078.17 Cr in Q1 FY27 and Rs 1,449.02 Cr in Q2 FY26. Net gain on fair value changes stood at Rs 648.11 Cr for the quarter. The company maintained a book value security cover of 1.21x and a market value security cover of 1.59x on its listed secured debt securities.
high confidence
What changedSammaan Capital approved and declared its Q2 and H1 FY27 standalone and consolidated financial results along with statutory debt security cover filings.
Why it mattersProvides visibility into the ongoing business transition, asset-light originations, and debt servicing security coverage following recent restructuring and capital infusions.
Interest income (Q2): Rs 1,161.26 CrNet gain on fair value changes (Q2): Rs 648.11 CrSecurity cover on book value: 1.21Secured debt securities covered: Rs 14,972.25 Cr
📅 Short termMarket focus will center on loan book trends, collection efficiency, and co-lending volumes detailed in the full earnings disclosure.
📈 Long termExecution of the asset-light retail mortgage origination model and expansion towards the targeted 500 branches remain central to sustainable profitability.
⚠ Risk flags
Subsidiaries reported net losses of Rs 29.62 Cr in Q2
Revaluation impact of Rs 1,027 Cr on external commercial borrowings and foreign currency bonds
👀 What to Watch
Monitor full quarterly profit/loss metrics, legacy loan book rundown, and progress on retail co-lending originations.
Azad Targets ₹1,300+ Cr Revenue Run Rate by FY28; Commissions All 6 Dedicated OEM Facilities
Azad Engineering released its Q2 FY27 earnings call transcript, highlighting that all 6 customer-dedicated manufacturing facilities (44,800 sq m) across 4 global OEMs are now commissioned. For Q2 FY27, standalone revenue grew 31.6% YoY to ₹187.8 crore, with EBITDA at ₹70.4 crore (37.5% margin) and PAT at ₹30.8 crore (16.4% margin). Front-loaded investments led to a doubling of depreciation to ₹21.8 crore and increased employee costs of ₹50.3 crore. Management expects throughput from new capacity to ramp up from Q4 FY27, targeting an annual revenue run rate of over ₹1,300 crore by the end of FY28 (compared to FY26 revenue of ₹603.4 crore).
high confidence
What changedFiling of the Q2 FY27 earnings conference call transcript following the operational commissioning of all six dedicated OEM manufacturing facilities.
Why it mattersConfirms the completion of the heavy setup/capex phase, setting the timeline for converting expanded capacity into over ₹1,300 crore in annual run-rate revenue by FY28.
📅 Short termOperating margins may see temporary pressure from front-loaded hiring and doubled depreciation until revenue throughput accelerates in Q4 FY27.
📈 Long termCommissioned customer-dedicated facilities and multi-year supply contracts provide strong visibility towards management's 25%+ long-term annual growth guidance.
⚠ Risk flags
High client concentration across key global energy OEMs (Mitsubishi, GE Vernova, Siemens, Baker Hughes)
Execution and qualification delays during the delta qualification ramp-up phase
👀 What to Watch
Track the revenue ramp-up and operating leverage from Q4 FY27 into H1 FY28 as client qualifications conclude across newly commissioned facilities.
USFDA Concludes LiqMeds UK Inspection with 4 Observations
Zydus Lifesciences announced the closure of a USFDA inspection at its LiqMeds facility in the UK. The audit took place from November 9 to November 13, 2026, and concluded with 4 observations. The company confirmed it will work closely with the USFDA to address these observations expeditiously. Investors should track the subsequent classification of the inspection (VAI vs OAI) by the regulator.
high confidence
What changedThe USFDA completed a regulatory audit of Zydus' UK-based LiqMeds facility, issuing 4 observations.
Why it mattersUS regulatory compliance is critical for Zydus' US sales and pipeline approvals; unresolved observations could potentially delay future product approvals from this site.
Number of observations: 4Inspection start date: 9th November, 2026Inspection end date: 13th November, 2026
📅 Short termLikely neutral to slightly cautious pending details on whether the 4 observations are procedural or data-integrity/critical in nature.
📈 Long termLimited, provided the company resolves the observations promptly and receives a Voluntary Action Indicated (VAI) or EIR closure.
⚠ Risk flags
Risk of escalation to Warning Letter or Official Action Indicated (OAI) if the corrective actions fail to satisfy the USFDA.
👀 What to Watch
Monitor the company's response submission within the 15-day window and watch for the USFDA's final Establishment Inspection Report (EIR) classification (NAI/VAI vs OAI).
H1 FY27 Net Loss at ₹3.35 Cr on Revenue of ₹139.69 Cr; Total Debt Reaches ₹184.13 Cr
Vels Film International reported its consolidated financial results for the half-year ended September 30, 2026, posting revenue from operations of ₹139.54 Cr (₹13,953.62 Lakhs) compared to ₹1.35 Cr in H1 FY26. Consolidated net loss for the period narrowed to ₹3.35 Cr (loss of ₹335.25 Lakhs) from a loss of ₹4.51 Cr in H1 FY26. Total borrowings rose to ₹184.13 Cr (₹72.33 Cr long-term and ₹111.79 Cr short-term) against a shareholder net worth of just ₹36.31 Cr. The Board also appointed Dr. Saravanan Chandran as an Additional Independent Director for a 5-year term.
high confidence
What changedReported H1 FY27 financial results showing inventory unwinding, substantial revenue recognition, but continued net losses and high debt levels.
Why it mattersFinance costs of ₹9.71 Cr for six months continue to weigh heavily against operating earnings, keeping the company in net losses despite substantial top-line delivery.
Consolidated Revenue (H1 FY27): ₹139.69 CrConsolidated Net Loss (H1 FY27): ₹3.35 CrFinance Costs (H1 FY27): ₹9.71 CrStandalone Total Borrowings: ₹184.13 CrTotal Borrowings vs Market Cap: ~160%
📅 Short termMarket may take note of the narrowed losses and strong top-line scale, though high debt and interest charges remain immediate headwinds.
📈 Long termProfitability remains constrained by high leverage; long-term sustainability hinges on successful monetisation of digital/satellite rights and debt reduction.
⚠ Risk flags
High debt burden with ₹111.79 Cr in short-term borrowings and ₹72.33 Cr in long-term borrowings vs ₹36.31 Cr equity
Negative net cash from operating activities of ₹3.56 Cr for H1 FY27
Heavy finance costs consuming operating profit
👀 What to Watch
Track whether subsequent film releases generate positive cash flows to reduce the heavy short-term debt burden of ₹111.79 Cr and finance charges.
CPS Shapers Wins ₹41.5 Lakh Order from Tilal Industries for Trunks & Briefs
C P S Shapers Limited has secured a domestic purchase order valued at ₹41,50,000 (excluding GST) from Tilal Industries Private Limited. The scope of work covers the manufacturing and supply of various kinds of trunks and briefs according to prescribed specifications. Delivery of the order is scheduled to be completed by January 2027. While this marks an expansion in innerwear manufacturing, the contract value is relatively modest compared to historical semi-annual revenues (₹17.62 crore in H1 FY24).
high confidence
What changedCPS Shapers bagged a new commercial manufacturing order worth ₹41.50 lakh for trunks and briefs from Tilal Industries.
Why it mattersDemonstrates customer acquisition in the innerwear contract manufacturing segment, though the small deal size limits near-term financial impact.
Order value: Rs. 41,50,000.00Execution deadline: January 2027Customer: TILAL INDUSTRIES PRIVATE LIMITED
📅 Short termLimited stock price impact given the small order size relative to the overall business scale.
📈 Long termLimited; acts as an incremental step in building third-party manufacturing relationships in the men's innerwear category.
⚠ Risk flags
Small contract size
Execution timeline extending to January 2027
👀 What to Watch
Track execution and revenue recognition by January 2027, alongside any margin accretion from expanding contract manufacturing volumes in innerwear.
TICL Reports Q2 FY27 Net Profit of ₹0.72 Cr; Revenue at ₹12.78 Cr with Significant Audit Qualifications
Twamev Construction and Infrastructure Limited (TICL) announced its Q2 FY27 results, reporting revenue of ₹12.78 crore and a net profit of ₹0.72 crore (EPS of ₹0.05). Revenue quality remains vulnerable, with ₹10.56 crore out of ₹12.78 crore stemming from unbilled revenue and ₹0.998 crore from an arbitration award. Auditors issued multiple qualifications and emphasis of matters, including an unsettled resolution plan payment of ₹2,100 lakh, legacy claims of ₹98,618 lakh against NHAI in step-down subsidiary TRPL, and an unprovided NBFC loan of ₹543.83 lakh.
high confidence
What changedTICL declared its un-audited standalone and consolidated Q2 FY27 financial results and published accompanying auditor review qualifications.
Why it mattersWhile the business remains marginally profitable on paper, substantial revenue is unbilled and legacy dispute overhangs from its CIRP restructuring continue to obscure asset quality.
Q2 Turnover / Total Income: ₹1,381 LakhQ2 Net Profit: ₹72 LakhUnbilled Revenue in Q2: ₹1,056 LakhTotal Unbilled Revenue Balance: ₹1,480 LakhResolution Plan Settlement Amount: ₹2,100 LakhQuarterly revenue vs TTM revenue: ~19.1%
📅 Short termMarket sentiment is likely to remain cautious due to persistent auditor qualifications and heavy dependence on unbilled revenue and arbitration interest for quarterly profitability.
📈 Long termStructural turnaround depends on resolving historical debt settlements (₹2,100 lakh), regularizing accounts from NPA status, and converting its ₹325-330 crore order book into billed cash flow.
⚠ Risk flags
High unbilled revenue component (₹10.56 crore of ₹12.78 crore Q2 revenue)
Significant audit qualifications regarding legacy subsidiary liabilities and NPA loans
Non-provision of employee benefits (gratuity and leave encashment under Ind AS 19)
👀 What to Watch
Track the resolution plan settlement of ₹2,100 lakh and the conversion rate of ₹14.80 crore in unbilled revenue into realized cash flows over upcoming quarters.
Solex Energy Q2 FY27 PAT Drops 33% YoY to ₹3.9 Cr Despite 76% Revenue Rise; Orders Top ₹4,000 Cr
Solex Energy reported consolidated revenue of ₹274.3 crore (up 75.8% YoY) for Q2 FY27, supported by higher module shipment volumes. However, net profit declined 32.7% YoY and 52.9% QoQ to ₹3.9 crore (PAT margin compressed to 1.4%), impacted by lower capacity utilization amid regulatory procurement uncertainty around ALMM List-II. Management noted strong order visibility exceeding ₹4,000 crore (over 2.3x TTM revenue), including ₹1,050 crore in confirmed orders with advances. Additionally, the company's subsidiary approved a ₹150 crore Compulsorily Convertible Debenture (CCD) issuance to support expansion.
high confidence
What changedSolex Energy reported Q2 FY27 operational numbers reflecting sharp revenue growth but significant margin compression, alongside an order visibility pipeline exceeding ₹4,000 crore and a subsidiary ₹150 crore CCD issuance.
Why it mattersWhile top-line scaling demonstrates robust demand for TOPCon modules, regulatory pauses and inventory delays compressed PAT margins to just 1.4%, highlighting operational leverage sensitivity.
Q2 FY27 Revenue: ₹2,743 millionQ2 FY27 PAT: ₹39 millionQ2 FY27 EBITDA Margin: 10.4%Order book visibility: > ₹4,000 croreLargest single order won: ₹628.37 croreOrder visibility vs TTM Revenue: ~230%
📅 Short termProfitability remains under pressure from regulatory transition delays and lower utilization, though dispatches should improve as post-September supplies flow through.
📈 Long termBackward integration into a planned 2.2 GW solar cell manufacturing plant and scaling the 4 GW module platform are critical to insulate margins from cell price volatility and policy shifts.
⚠ Risk flags
Severe margin compression (PAT margin at 1.4% vs 3.7% YoY).
Vulnerability to regulatory delays and ALMM policy changes halting procurement.
High balance sheet leverage (Debt-to-Equity at 1.59x prior to additional debt/CCD obligations).
👀 What to Watch
Track margin recovery in H2 FY27 following normalized inventory inflows post-September, and monitor the conversion of the ₹3,000 crore advanced-stage pipeline into confirmed orders.
Open Offer at ₹1.00/share for 26% Stake Triggered by Management Takeover
Acquirers Ms. Chinkita R Agarwal and Mrs. Naina Saideep Agarwal (along with PAC Mr. Saideep Agarwal) have announced an open offer to acquire up to 3,48,05,272 equity shares (26.00% of the expanded voting share capital) of Money Masters Leasing & Finance Ltd at ₹1.00 per share. The open offer is triggered by a Share Purchase Agreement to acquire 3,47,87,740 shares (34.66% existing stake) from the existing promoters at ₹1.00 each, alongside a board-approved preferential allotment of 3,34,84,139 equity shares to the Acquirers. The total consideration for the open offer stands at ₹3.48 Cr assuming full acceptance, representing more than 50% of the company's current market cap of ₹6 Cr. The underlying control change is subject to regulatory approval from the Reserve Bank of India.
high confidence
What changedA complete change in promoter control was initiated via a 34.66% secondary buyout (SPA) and preferential allotment, triggering a mandatory 26% open offer by the incoming Acquirers.
Why it mattersThe infusion and management change bring in new promoters into an NBFC with a market cap of only ₹6 Cr and an offer consideration of ₹3.48 Cr, potentially reshaping its capital base and business direction.
📅 Short termThe offer price of ₹1.00 provides a grounded benchmark above the current market price (₹0.70), and trading may adjust near the offer price pending tender dates.
📈 Long termStructural impact depends on RBI granting regulatory approvals and the new promoters' capital infusion strategy to expand the NBFC's lending book.
⚠ Risk flags
Deal completion is strictly conditional on prior RBI approval for change in control and shareholding over 26%.
Equity dilution from 3.35 Cr preferential shares issued to Acquirers.
👀 What to Watch
Track the Detailed Public Statement (DPS) scheduled on or before November 20, 2026, and watch for the timeline of Reserve Bank of India (RBI) approval required for the change in ownership and management.
Sreeleathers Q2 FY27 PAT Rises 14.8% YoY to ₹9.88 Cr; Guides Q3 Revenue at ₹67-70 Cr
Sreeleathers reported an 11.3% YoY rise in Q2 FY27 revenue from operations to ₹83.16 Cr, driven by pre-Durga Puja shopping, though slightly missing its internal guidance of ~₹86 Cr due to warehouse dispatch bottlenecks. Profit after tax rose 14.8% YoY to ₹9.88 Cr, with operating EBITDA margin expanding 33 bps to 16.0%. Company-owned and company-operated (COCO) stores outpaced overall growth, recording a 24.5% YoY revenue increase. For Q3 FY27, management guided revenue between ₹67 Cr and ₹70 Cr (up 10% to 15% YoY), reflecting post-Puja, Diwali, and Christmas festive sales.
high confidence
What changedSreeleathers published its detailed Q2 FY27 business update and press release, detailing festive trading trends and providing explicit Q3 revenue guidance.
Why it mattersDemonstrates robust festive retail demand in Eastern India and margin stability despite warehouse dispatch constraints that deferred some wholesale billing to Q3.
📅 Short termFestive momentum from Durga Puja, Diwali, and Christmas is expected to support Q3 top line, with deferred wholesale billings from late September landing in Q3.
📈 Long termContinued debt-free balance sheet and steady store expansion offer resilience, though solving warehouse dispatch capacity will be key to sustaining double-digit sales growth during peak periods.
⚠ Risk flags
Warehouse dispatch constraints leading to order bunching and delivery delays during peak demand.
Gross margin contraction of 138 bps YoY to 22.1% in Q2 FY27.
👀 What to Watch
Track whether warehouse bottlenecks normalize to allow slipped wholesale orders to be billed in Q3, and watch if Q3 revenue meets the ₹67-70 Cr guidance range.
Kallam Textiles has notified stock exchanges of a delay in submitting its unaudited financial results for the half-year ended September 30, 2026. The delay is attributed to operational challenges, management transition, and data reconciliation under the Corporate Insolvency Resolution Process (CIRP). The NCLT Amravati Bench had admitted the Section 7 IBC petition against the company on April 06, 2026, suspending board powers in favor of the Resolution Professional. The company carries severe financial distress, including a debt of ₹389 Cr against a market cap of ₹11 Cr.
high confidence
What changedKallam Textiles missed its statutory deadline under Regulation 33 of SEBI LODR for submitting half-year financial results ended September 30, 2026.
Why it mattersThe delay underscores severe administrative and operational disruption under CIRP, raising risks of exchange penalties or trading suspension for a company already burdened with ₹389 Cr in debt.
Half-year period ended: 30th September, 2026NCLT CIRP admission date: April 06, 2026Debt vs Market Cap: ~35.3xTTM Net Loss: ₹-87 Cr
📅 Short termExchanges may issue compliance notices or levy fines for delayed reporting under LODR Regulation 33.
📈 Long termEquity value remains severely impaired as the company undergoes resolution under IBC with massive outstanding liabilities relative to its asset base.
⚠ Risk flags
Ongoing Corporate Insolvency Resolution Process (CIRP)
Suspension of Board of Directors
Potential regulatory action or trading suspension for reporting non-compliance
Extremely high leverage with D/E of 13.46
👀 What to Watch
Track subsequent filings for the delayed Q2 financial results and monitor developments regarding the CIRP resolution plan or liquidation proceedings at NCLT.
SRIT Wins ₹128.93 Cr (QAR ~50M) International Order from Ooredoo QPSC
SRIT India Limited's branch in Doha QFC, Qatar, has secured a major international contract valued at QAR ~50 million (approx. ₹128.93 crore / ₹1,289.3 million) from Ooredoo QPSC. The scope involves managed services for Electronic Health and Information Systems for Pharmacy & Drug Control Departments. Execution covers 2 years for healthcare onboarding and 3 years for managed services of the E-Health ecosystem and rollout operations. Compared to recent quarterly revenues (e.g. ₹104.70 crore in Sep 2026), this contract represents an order size larger than an entire single quarter's top line.
high confidence
What changedSRIT has bagged a ₹128.93 crore multi-year healthcare IT managed services contract in Qatar from telecom major Ooredoo QPSC.
Why it mattersThe order value exceeds the company's recent single-quarter revenue (₹104.70 cr in Sep 2026), providing strong multi-year international revenue visibility and expanding its footprint in Middle East healthcare systems.
Order value (QAR): QAR ~50millionOrder value (INR): ₹1,289.3 MillionExecution tenure (Onboarding): 2 yearsExecution tenure (Managed Services): 3 yearsOrder vs Sep 2026 quarter revenue: ~123%
📅 Short termPositive sentiment driver as the sizable international win strengthens order book visibility across the next 2-3 years.
📈 Long termEnhances SRIT's credentials in large-scale national health-tech and drug control systems internationally, potentially opening avenues for further public-sector healthcare contracts in the GCC region.
⚠ Risk flags
Cross-border execution risks and foreign currency exchange fluctuations (QAR/INR)
Milestone delivery and operational execution over 2-3 years
👀 What to Watch
Track the project onboarding progress and observe revenue recognition milestones from this international contract in subsequent quarterly financial filings.
Saudi Water Authority Cancels ₹2,332 Cr Desalination Plant Tender Awarded to WABAG
VA Tech Wabag announced that the Saudi Water Authority has cancelled the tender for a 300 MLD Mega Sea Water Desalination Plant at Yanbu, Kingdom of Saudi Arabia, citing internal customer reasons via the Etimad portal. The project was previously awarded to WABAG in July 2025 and valued at approximately USD 272 million (SAR 1,019 million / ₹2,332 crore). This cancelled contract represents ~54.7% of WABAG's TTM revenue of ₹4,262 crore and nearly 14.6% of its ₹16,000 crore order book. WABAG is in the process of approaching the client to understand the decision and determine the next course of action.
high confidence
What changedA previously awarded mega-order of ₹2,332 crore in Saudi Arabia was officially cancelled by the client prior to final counter-signing and commencement.
Why it mattersThe cancellation strips out an order equivalent to over half of TTM revenue (~54.7%), lowering future revenue visibility and international growth momentum in Saudi Arabia.
Cancelled order value (INR): INR 2,332 CroresCancelled order value (USD): USD 272 MillionPlant Capacity: 300 MLDCancelled order vs TTM revenue: ~54.7%Cancelled order vs total order book: ~14.6%
📅 Short termNegative sentiment is likely to weigh on the stock as the market adjusts for the de-recognition of a ₹2,332 crore mega contract from the backlog.
📈 Long termWhile WABAG still maintains a robust order book (~₹13,600+ crore remaining), losing a marquee Middle East desalination project poses headwinds to international expansion targets.
⚠ Risk flags
Order backlog reduction
Client / geopolitical cancellation risk in overseas public tenders
Loss of revenue visibility in the MENA region
👀 What to Watch
Track management commentary in upcoming investor calls regarding order book adjustments, any potential tender re-bidding, or alternative order inflows in the MENA region.
Coal India Files RHP for Mahanadi Coalfields IPO to Offload up to 66.18 Cr Shares
Coal India Limited has filed a Red Herring Prospectus (RHP) dated November 13, 2026, for the proposed initial public offering (IPO) of its wholly owned subsidiary, Mahanadi Coalfields Limited (MCL). The issue comprises an Offer for Sale (OFS) of up to 661,836,300 equity shares held by Coal India. The listing remains subject to market conditions, regulatory clearances, and final pricing. This transaction will monetize part of Coal India's holding in one of its primary production subsidiaries.
high confidence
What changedCoal India has officially initiated the listing process for its subsidiary MCL by filing the Red Herring Prospectus with SEBI and stock exchanges.
Why it mattersMonetizing up to 66.18 crore shares via OFS will generate substantial one-time cash inflows for Coal India, potentially supporting dividends or capital allocation while discovering market value for a key operating subsidiary.
Shares offered in OFS: up to 661,836,300RHP Date: 13th November, 2026
📅 Short termMarket sentiment may see a boost as value unlocking in a major operating subsidiary progresses toward launch over the coming weeks.
📈 Long termProvides transparent standalone market valuation for MCL, though Coal India will experience modest dilution of its earnings share depending on the percentage of equity offloaded.
⚠ Risk flags
Subject to market conditions and regulatory approvals
OFS pricing and net proceeds remain undisclosed until the price band is announced
👀 What to Watch
Track announcements regarding the price band, IPO launch dates, and the final valuation discovered for MCL, which will determine the quantum of cash unlocked for Coal India.
TNTELE Reports Q2 FY27 Net Loss of ₹4.49 Cr with Near-Zero Operational Income
Tamilnadu Telecommunications Limited reported its un-audited financial results for Q2 ended September 30, 2026, showing near-zero operations. Total income from operations was reported at ₹250 (in hundreds of rupees, effectively negligible at ~₹25,000), while net loss stood at ₹4.49 lakh hundreds (₹4.49 Cr) compared to a loss of ₹4.30 Cr in Q2 FY26. Basic and diluted EPS for the quarter was -₹0.98. The company's negative reserves widened to -₹247.16 Cr against an equity base of ₹45.68 Cr, highlighting ongoing going-concern risks.
high confidence
What changedFiling of the Q2 FY27 financial results showing widening losses and no meaningful operational revival.
Why it mattersThe company remains practically non-operational with mounting quarterly losses of ₹4.49 Cr, further eroding already negative net worth.
Net Loss (Q2 FY27): ₹4,49,230 (in Hundreds of Rupees)Total Income from Operations: ₹250 (in Hundreds of Rupees)H1 FY27 Net Loss: ₹7,90,566 (in Hundreds of Rupees)Paid up Equity Share Capital: ₹45,67,620 (in Hundreds of Rupees)Reserves (excluding Revaluation Reserve): (₹2,47,16,063) (in Hundreds of Rupees)
📅 Short termNegative sentiment is likely to persist as quarterly losses continue to accumulate without any top-line recovery.
📈 Long termSevere going concern uncertainties remain until operations restart or substantial recapitalization occurs.
⚠ Risk flags
Severe going concern uncertainty with negative net worth exceeding ₹200 Cr
Zero commercial manufacturing activity and operational revenue
Continuous quarterly cash burn driven by fixed and finance costs
👀 What to Watch
Monitor any announcements regarding revival plans, debt restructuring, or government promoter intervention given the deepening negative net worth.
Oriana Power Reports H1 FY27 Results; Details Asset Divestments to Actis and 1:5 Stock Split
Oriana Power has approved its unaudited standalone and consolidated financial results for the half year ended September 30, 2026. The company noted significant progress in its asset monetization strategy, having received consideration under SPAs with a PE fund managed by Actis India for two subsidiaries (TrueRe GUJ SPV and TrueRe Current). Multiple other subsidiaries were excluded from consolidation under AS 21 as they are held exclusively for imminent divestment. Additionally, the company implemented a 1:5 stock split with the record date on September 18, 2026, dividing face value ₹10 shares into ₹2 shares.
high confidence
What changedApproved H1 FY27 half-yearly results, confirmed execution of stock split from ₹10 to ₹2 face value, and reported progress on strategic asset divestments.
Why it mattersAsset sales to Actis are key to recycling capital into Oriana's 1 GW renewable development pipeline and maintaining balance sheet liquidity.
Stock split ratio: 1:5Paid-up share capital: ₹20,31,91,500Record date for share split: 18 September 202659 subsidiaries revenue (H1): ₹2,769.23 lakhs59 subsidiaries net loss (H1): ₹517.16 lakhs
📅 Short termMarket focus will center on liquidity enhancements from divestment proceeds and resolution of DISCOM approval conditions.
📈 Long termExecution of the developer-to-investor monetization pipeline is vital for sustaining the company's aggressive 100% growth ambitions.
⚠ Risk flags
Regulatory approval delays from revised DISCOM SOP requirements
Short-term losses across held-for-sale SPV subsidiaries
👀 What to Watch
Track the full cash inflow realization from the Actis India asset divestments and monitor whether revised DISCOM SOPs cause further closing delays.
Fusion CX Recommends ₹0.75 Final Dividend per Share; Fixes Record Date as Nov 27, 2026
Fusion CX Limited's Board of Directors has recommended a final dividend of ₹0.75 per equity share of face value ₹1 each (75%) for FY 2025-26. The dividend is subject to approval by shareholders at the ensuing Annual General Meeting (AGM) and, if declared, will be disbursed within 30 days of the AGM. The record date to identify eligible shareholders has been set as Friday, November 27, 2026. Alongside the dividend, the Board approved Q2 and H1 FY27 financial results and appointed three additional directors.
high confidence
What changedThe Board recommended a ₹0.75 per share final dividend, set November 27, 2026 as the record date, and reconstituted parts of the board and audit leadership.
Why it mattersProvides a direct cash return to shareholders (75% of face value) following the company's recent public listing, signaling operating cash generation.
Final Dividend per share: ₹ 0.75Face Value per share: ₹ 1Dividend percentage: 75%Record Date: November 27, 2026
📅 Short termStock will trade with dividend entitlement until the ex-date preceding November 27, 2026.
📈 Long termLimited; reflects standard post-earnings capital allocation and routine governance updates.
⚠ Risk flags
Dividend and auditor appointments are subject to shareholder approval at the AGM.
👀 What to Watch
Track the ex-dividend date around November 27, 2026, and watch for shareholder voting outcomes at the upcoming AGM regarding the dividend and board appointments.
⚠️How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI
🎁 Limited-time offer for early supporters
Our AI stock analytics, free on Telegram & WhatsApp
⚡ We track 3500+ companies instantly. As soon as a filing hits the NSE exchange, our AI reads it, summarizes it and tells you the impact in seconds.
Paid platforms charge ₹1,00,000+ a year for AI analytics like this. Join our channels and get it free.
